These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9098034)

  • 1. Patients who do better do better.
    Koretz RL
    Gastroenterology; 1997 Apr; 112(4):1418-20. PubMed ID: 9098034
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic hepatitis B and C with alpha interferon].
    Hess G
    Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon treatment in chronic hepatitis B].
    Pastore G; Santantonio T; Milella M; Iacovazzi T; Longo A; Pietromatera G
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):97-102. PubMed ID: 7619970
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis and alpha-2 interferon treatment of chronic hepatitis B].
    Pirotte J
    Rev Med Liege; 1996 Aug; 51(8):514-21. PubMed ID: 8927872
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Favorable outcome in chronic active hepatitis caused by B virus in childhood].
    Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A
    Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897
    [No Abstract]   [Full Text] [Related]  

  • 8. Membranous glomerulonephritis and chronic persistent hepatitis B in a child: treatment with recombinant interferon alfa.
    Jonas MM; Ragin L; Silva MO
    J Pediatr; 1991 Nov; 119(5):818-20. PubMed ID: 1941393
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
    Bayraktar Y; Uzunalimoglu B; Arslan S; Koseoglu T; Kayhan B; Telatar H
    Gut; 1993; 34(2 Suppl):S101. PubMed ID: 8314468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-interferon treatment of chronic hepatitis B infection: predictors of responsiveness.
    Dusheiko GM
    J Gastroenterol Hepatol; 1991; 6 Suppl 1():7-12. PubMed ID: 1751802
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon treatment of chronic viral hepatitis].
    Pirovino M
    Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between HLA class I antigens and response to interferon therapy in children with chronic HBV hepatitis.
    Giacchino R; Nocera A; Timitilli A; Cristina E; Giambartolomei G; Caocci F; Cirillo C; Barocci S
    Arch Virol Suppl; 1992; 4():281-3. PubMed ID: 1450702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic infection due to hepatitis B virus in patients less than 16 years of age: therapeutic approach by means of interferon alfa-2b].
    Vetencourt R; Oropeza F; de Armas J; Cordero I; de Silva M; Machado I; Vetencourt M; Mendoza J
    G E N; 1990; 44(4):353-60. PubMed ID: 2152277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic viral hepatitis--benefits of current therapies.
    Hoofnagle JH; Lau D
    N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Giustina G; Pedini B; Alberti A
    Arch Virol Suppl; 1992; 4():291-3. PubMed ID: 1450705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon therapy in chronic hepatitis B and delta infection in children].
    Nisevich NI; Uchaĭkin VF; Sokolova NV; Kuznetsov VP; Syr'eva TN; Cherednichenko TV; Kaganov BS; Moleva TP; Iusuf-zade AA; Guseva LN
    Vestn Akad Med Nauk SSSR; 1991; (11):56-9. PubMed ID: 1767580
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term follow-up of HBeAg-positive patients after interferon-alpha treatment for chronic hepatitis B].
    Goeser T
    Z Gastroenterol; 1997 Mar; 35(3):233-5. PubMed ID: 9173693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.